TagsRheumatology 
Artificial Intelligence-powered Flare Risk Prediction in Managing Rheumatoid Arthritis

Rheumatoid arthritis (RA) is a chronic inflammatory disease that can create joint damage and bone destruction, causing severe pain and disability. The disease also manifests as extra-articular disease, that can affect most organs of the body, with a...

Aug 11, 2023
Consensus Recommendations on COVID-19 Vaccination

Consensus Recommendations on COVID-19 Vaccination in Adult Patients with Autoimmune Rheumatic Diseases by the HKSR Clinical opinions generally advocate that COVID-19 vaccination is a critical measure to contain the current pandemic. Notably, patient...

Sep 17, 2021
A Great Leap forward in Therapeutic Development

A Great Leap forward in Therapeutic Development Discoveries of molecular mechanisms of different diseases provide unprecedented opportunities to develop novel medicines. However, the research and development of a brand-new drug is time-consuming and...

Jun 21, 2021
The Establishment of Consensus Statements on Management of Systemic Lupus Erythematosus for Asia-Pacific Region

The Establishment of Consensus Statements on Management of Systemic Lupus Erythematosus for Asia-Pacific Region Systemic lupus erythematosus (SLE) is a multi-systemic autoimmune disease characterised by periods of exacerbation and remission, with or...

Jun 21, 2021
Golimumab Improves Sleep Problems and Pain in AS Patients

Adult patients with active ankylosing spondylitis (AS) treated with intravenously (IV) administered an anti-tumor necrosis factor (anti-TNF) monoclonal antibody, golimumab (GOL), demonstrated improvements in sleep problems, total back pain (TBP) and...

May 5, 2020
Risk of Serious Infections in Tofacitinib versus Other Biologic Drug Initiators in Patients with Rheumatoid Arthritis

Biologic or targeted synthetic disease modifying anti-rheumatic drugs (DMARDs) are well-known for increasing the risk of serious infections (SI). Few studies conducted in real-world setting directly compared the incidence rate (IR) of serious bacter...

Apr 22, 2020
Real Life 12Year Retention Rate of Subcutaneous Anti-TNF in Spondyloarthritis.Results from a Multicenter Cohort of 1170 Patients

Real Life 12 Year Retention Rate of Subcutaneous Anti-TNF in Spondyloarthritis. Results from a Multicenter Cohort of 1170 Patients By Dr. Andus Ng Spondyloarthritis (SpA) patients starting golimumab (GOL) have the best drug retention compared to tho...

Mar 30, 2020
Risk Prediction and Preconception Counselling on Adverse Pregnancy Outcomes in Systemic Lupus Erythematosus

Risk Prediction and Preconception Counselling on Adverse Pregnancy Outcomes in Systemic Lupus Erythematosus Pregnancy is challenging for both women with systemic lupus erythematosus (SLE) and their treating physicians as it is associated with an inc...

Mar 16, 2020